Correction of hypertension by normalization of endothelial levels of fibroblast growth factor and nitric oxide synthase in spontaneously hypertensive rats.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1996-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.93.21.11996PMID 8876251PMCID PMC38172
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathogenesis of myocardial fibrosis in spontaneously hypertensive rats (SHR).

  1995cited by this paper
• Hypertension in mice lacking the gene for endothelial nitric oxide synthase

  1995cited by this paper
• Basic fibroblast growth factor increases nitric oxide synthase production in bovine endothelial cells.

  1995cited by this paper
• Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

  1995cited by this paper
• Influence of isradipine treatment on the morphology of the aorta in spontaneously hypertensive rats

  1994cited by this paper
• Cell Signal Transduction, Second Messengers and Protein Phosphorylation in Health and Disease

  1994cited by this paper
• Fibroblast growth factors, proteins with a broad spectrum of biological activities.

  1994cited by this paper
• Systemic gene expression after intravenous DNA delivery into adult mice.

  1993cited by this paper
• Structural changes in the endothelium of the femoral artery of spontaneously hypertensive rats: sensitivity to isradipine treatment

  1993cited by this paper
• Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization.

  1993cited by this paper
• Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform.

  1992cited by this paper
• High-level synthesis in Escherichia coli of shortened and full-length human acidic fibroblast growth factor and purification in a form stable in aqueous solutions.

  1992cited by this paper
• Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix.

  1992cited by this paper
• A novel cationic liposome reagent for efficient transfection of mammalian cells.

  1991cited by this paper
• Hypotensive activity of fibroblast growth factor.

  1991cited by this paper
• Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension.

  1990cited by this paper
• Expression of basic fibroblast growth factor in normal human tissues.

  1990cited by this paper
• Regulation of gene expression in vivo by liposome-mediated delivery of a purified transcription factor.

  1990cited by this paper
• VIP-mRNA is increased in hypertensive rats.

  1989cited by this paper
• Role of endothelium-derived nitric oxide in the regulation of blood pressure.

  1989cited by this paper
• Pharmacokinetics and Distribution of Heparin‐Binding Growth Factor I (Endothelial Cell Growth Factor) in the Rat

  1989cited by this paper
• The heparin-binding (fibroblast) growth factor family of proteins.

  1989cited by this paper
• The fate of intravenously administered bFGF and the effect of heparin.

  1989cited by this paper
• Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat.

  1986cited by this paper
• A specific deficiency in paraventricular vasopressin and oxytocin in the spontaneously hypertensive rat.

  1982cited by this paper
• Reduced content of vasopressin in the brain of spontaneously hypertensive as compared to normotensive rats.

  1981cited by this paper
• Central neural peptides and catecholamines in spontaneous and DOCA/salt hypertension.

  1981cited by this paper
• Regional changes in the activities of aminergic biosynthetic enzymes in the brains of hypertensive rats.

  1977cited by this paper
• Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats.

  1971cited by this paper
• Development of a strain of spontaneously hypertensive rats.

  1963cited by this paper

• Fibroblast Growth Factor Type 2 (FGF2) Administration Attenuated the Clinical Manifestations of Preeclampsia in a Murine Model Induced by L-NAME

  2021cites this paper
• Acute Kidney Injury Sensitizes the Brain Vasculature to Ang II (Angiotensin II) Constriction via FGFBP1 (Fibroblast Growth Factor Binding Protein 1)

  2020cites this paper
• Topically Applied Etamsylate: A New Orphan Drug for HHT-Derived Epistaxis (Antiangiogenesis through FGF Pathway Inhibition)

  2019cites this paper
• Genome‐Wide Meta‐Analysis of Blood Pressure Response to β1‐Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies)

  2019cites this paper
• Blood Pressure Control by a Secreted FGFBP1 (Fibroblast Growth Factor–Binding Protein)

  2018cites this paper
• Gender-Specific Association Between FGFR4 Gly388Arg Gene Variants and Hypertension

  2017cites this paper
• Deciphering the Role of Glycine134 in the Human Acidic Growth Factor-1’s Binding to Heparin

  2016cites this paper
• Neural Stem Cells and Induced Neurons for Nerve Injury Repair

  2015cites this paper
• Diacetyloxyl derivatization of the fibroblast growth factor inhibitor dobesilate enhances its anti-inflammatory, anti-angiogenic and anti-tumoral activities

  2015cites this paper
• Role of Rutin on Nitric Oxide Synthesis in Human Umbilical Vein Endothelial Cells

  2014cites this paper
• Microvascular Plasticity After Experimental Stroke: A Molecular and MRI Study

  2014cites this paper
• Effect of hypertension on the structural and functional integrity of the young and aged brain in an inducible transgenic model

  2014cites this paper
• Antihypertensive effects of extract from Picrasma quassiodes (D. Don) Benn. in spontaneously hypertensive rats.

  2013cites this paper
• Spatial distribution and modulation of nitric oxide synthase in a hypertensive rat model

  2012cites this paper
• Advances in Growth Factor Delivery for Therapeutic Angiogenesis

  2012cites this paper
• Rôle du stress oxydant en période néonatale dans l'hypertension artérielle et la dysfonction vasculaire et métabolique de l'adulte

  2011cites this paper
• Mechanistic insights into copper-induced regression of heart hypertrophy

  2011cites this paper
• Gene transfer to the mammalian reproductive tract†

  2010cites this paper
• Dangyuja (Citrus grandis Osbeck) Peel Improves Lipid Profiles and Alleviates Hypertension in Rats Fed a High-Fat Diet

  2010cites this paper
• Efecto de Cocoanox, un cacao rico en polifenoles, en ratas espontáneamente hipertensas

  2010cites this paper
• Gentisic Acid, a Compound Associated with Plant Defense and a Metabolite of Aspirin, Heads a New Class of in Vivo Fibroblast Growth Factor Inhibitors*

  2010cites this paper
• PMCA as a regulator of calcium/calmodulin-dependent signal transduction pathways

  2009cites this paper
• Circulating vascular endothelial growth factor and nitric oxide in patients with liver cirrhosis: A possible association with liver function impairment

  2009cites this paper
• The FGF family: biology, pathophysiology and therapy

  2009cites this paper
• Nitrones as therapeutics.

  2008cites this paper
• Chapter 37 – Therapeutic Potential of Systemic Gene Transfer Strategy for Hypertension and Cardiovascular Disease

  2007cites this paper
• Revascularization of trachea in lung and tracheal transplantation

  2007cites this paper
• Cardiovascular gene delivery: The good road is awaiting.

  2006cites this paper
• Novel ideas of gene therapy for atherosclerosis: modulation of cellular signal transduction of TGF-beta family.

  2006cites this paper
• Nitric oxide pathway as new drug targets for refractory hypertension.

  2005cites this paper
• Therapeutic Angiogenesis for the Treatment of Coronary Artery Disease : Can We Improve the Results?

  2005cites this paper
• Current and Future Novel Targets of Gene Therapy for Hypertension

  2005cites this paper
• Overexpression of Inducible Nitric Oxide Synthase in the Kidney of the Spontaneously Hypertensive Rat

  2005cites this paper
• Effects of boiling on the antihypertensive and antioxidant activities of onion.

  2004cites this paper
• In vitro transfection of the human vas deferens using DNA-liposome and DNA-neutral lipid complexes.

  2004cites this paper
• Protein-, gene-, and cell-based therapeutic angiogenesis for the treatment of myocardial ischemia

  2004cites this paper
• Reversible suppression of nitric oxide system in essential hypertension

  2003cites this paper
• Diminished Expression of Constitutive Nitric Oxide Synthases in the Kidney of Spontaneously Hypertensive Rat

  2003cites this paper
• Angiogenic protein therapy.

  2003cites this paper
• Decorin Reverses the Repressive Effect of Autocrine-Produced TGF-β on Mouse Macrophage Activation1

  2003cites this paper
• Vascular growth factors and angiogenesis in cardiac surgery.

  2003cites this paper
• Basic fibroblast growth factor increases collateral blood flow in spontaneously hypertensive rats.

  2003cites this paper
• Syndecan-4 modulates basic fibroblast growth factor 2 signaling in vivo.

  2003cites this paper
• In vivo transfection of the mouse vas deferens.

  2002cites this paper
• Serum basic fibroblast growth factor levels in exercise-induced myocardial ischemia more likely a marker of endothelial dysfunction than a marker of ischemia?

  2002cites this paper
• Effects of aging and AT-1 receptor blockade on NO synthase expression and renal function in SHR.

  2002cites this paper
• Association of renal injury with nitric oxide deficiency in aged SHR: prevention by hypertension control with AT1 blockade.

  2002cites this paper
• Impaired regulation of renal oxygen consumption in spontaneously hypertensive rats.

  2002cites this paper
• Physiological mechanisms regulating the expression of endothelial-type NO synthase.

  2002cites this paper
• Alterations of the Nitric Oxide Pathway in Cerebral Arteries from Spontaneously Hypertensive Rats

  2002cites this paper
• BASIC FIBROBLAST GROWTH FACTOR AND HYPERTENSIVE DISORDERS IN PREGNANCY

  2002cites this paper
• Generation of transgenic mice by transfection of pronuclear embryos using lipid-DNA complexes

  2002cites this paper
• Therapeutic angiogenesis in cardiology using protein formulations.

  2001cites this paper
• Vascular gene transfer driven by endoglin and ICAM-2 endothelial-specific promoters

  2001cites this paper
• Fibroblast growth factors in myocardial ischemia / reperfusion injury and ischemic preconditioning

  2001cites this paper
• Gene Therapy for Cardiovascular Disease: A Case for Cautious Optimism

  2001cites this paper
• Impaired endothelial function in transgenic mice expressing both human renin and human angiotensinogen.

  2000cites this paper
• Transcriptional Induction of Endothelial Nitric Oxide Gene by Cyclosporine A

  2000cites this paper
• Mesenteric Cyclooxygenase Products After Combined Antihypertensive Treatment in Uninephrectomized SHRs

  2000cites this paper
• NO and de novo mammalian angiogenesis: Further evidence that NO inhibits bFGF‐induced angiogenesis while not influencing VEGF165‐induced angiogenesis

  2000cites this paper
• This information is current as Macrophages Is Cell Cycle Dependent The Expression of MHC Class II Genes in and

  2000cites this paper
• In-vivo transfection of the female reproductive tract epithelium.

  2000cites this paper
• Extracellular Signal-Regulated Kinase Pathway Is Involved in Basic Fibroblast Growth Factor Effect on Angiotensin II–Induced Ca2+ Transient in Vascular Smooth Muscle Cell From Wistar-Kyoto and Spontaneously Hypertensive Rats

  2000cites this paper
• The Expression of MHC Class II Genes in Macrophages Is Cell Cycle Dependent1

  2000cites this paper
• Extracellular signal-regulated kinase pathway is involved in basic fibroblast growth factor effect on angiotensin II-induced Ca(2+) transient in vascular smooth muscle cell from Wistar-Kyoto and spontaneously hypertensive rats.

  2000cites this paper
• Blood flow regulates the development of vascular hypertrophy, smooth muscle cell proliferation, and endothelial cell nitric oxide synthase in hypertension.

  2000cites this paper
• Decrease of endothelial nitric oxide synthase in stroke-prone spontaneously hypertensive rat cerebral cortex.

  2000cites this paper
• Neural mechanisms in nitric-oxide-deficient hypertension.

  1999cites this paper
• Role of Vascular Endothelial Growth Factor in Regulation of Angiogenesis

  1999cites this paper
• Ontogenetic aspects of hypertension development: analysis in the rat.

  1999cites this paper
• Molecular and biological properties of vascular endothelial growth factor

  1999cites this paper
• Expression of beta-galactosidase gene and endothelial nitric oxide synthase gene in rat vascular smooth muscle cells after in vitro lipotransfection.

  1999cites this paper
• Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats.

  1999cites this paper
• Vascular gene transfer : from bench to bedside.

  1999cites this paper
• Vascular Endothelial Growth Factor Molecular and Biological Aspects

  1999cites this paper
• Role of vascular endothelial growth factor in the regulation of angiogenesis.

  1999cites this paper
• Vascular endothelial growth factor: molecular and biological aspects.

  1999cites this paper
• Increased Na,K,Cl cotransporter and Na, K-ATPase activity of vascular tissue in two-kidney Goldblatt hypertension.

  1998cites this paper
• Hypertensive Rats Upregulation of Renal and Vascular Nitric Oxide Synthase in Young Spontaneously

  1998cites this paper
• Endothelium-Derived Nitric Oxide and Control of Vascular Tone

  1998cites this paper
• Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats.

  1998influential citation
• Impaired cerebral cortex development and blood pressure regulation in FGF‐2‐deficient mice

  1998cites this paper
• The biology of vascular endothelial growth factor.

  1997cites this paper
• Cerebrovascular effects of nitric oxide manipulation in spontaneously hypertensive rats

  1997influential citation
• Loss of basic fibroblast growth factor in the subcommissural organ of old spontaneously hypertensive rats.

  1996cites this paper